Author: Lööser Reik
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.21, Iss.4, 2011-04, pp. : 585-591
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Leroy Vincent Thurairatnam Sukanthini
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. :
Cathepsin S inhibitors: 2004 –– 2010
By Lee-Dutra Alice Wiener Danielle K Sun Siquan
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 3, 2011-03 ,pp. :
Carbamate-based reversible inhibitors of cathepsin S and cathepsin K
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. :
Recent Advances in the Design of Cathepsin S Inhibitors
Current Topics in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-01 ,pp. :
Current Medicinal Chemistry, Vol. 13, Iss. 19, 2006-08 ,pp. :